YAP1 and small cell lung carcinoma: YAP1, a transcriptional coactivator of the Hippo signaling pathway, is frequently upregulated in non-neuroendocrine and mesenchymal-like SCLC tumors, particularly following chemotherapy or immune checkpoint blockade [88,89].